CPT® Code 86378

Deleted

1. Indications

The Migration Inhibitory Factor (MIF) test is indicated for various clinical scenarios where assessment of immune function is necessary. The following conditions and symptoms may warrant the performance of this test:

• Immunodeficiency Syndromes - The test is useful in evaluating patients suspected of having immunodeficiency syndromes, such as AIDS, DiGeorge syndrome, or Wiskott-Aldrich syndrome, where immune response may be compromised.
• Delayed-Type Hypersensitivity Reactions - It helps in assessing the immune response related to delayed-type hypersensitivity, which is crucial for diagnosing certain allergic reactions and infections.
• Evaluation of Immune Competence - The MIF test can be performed to determine the overall competence of the immune system, particularly in patients with unexplained infections or autoimmune conditions.

2. Procedure

The procedure for conducting the Migration Inhibitory Factor (MIF) test involves several key steps to ensure accurate measurement of MIF levels in response to specific antigens. The following procedural steps are typically followed:

• Step 1: Sample Collection - A blood sample is collected from the patient, usually via venipuncture. This sample will contain the lymphocytes necessary for the test.
• Step 2: Stimulation of Lymphocytes - The collected lymphocytes are then exposed to various antigens, including streptokinase-streptodornase, candida antigen, PPD, concanavalin A, phytohemagglutinin, and pokeweed. This stimulation is crucial for triggering the production of MIF.
• Step 3: Measurement of MIF Production - After stimulation, the levels of MIF produced by the lymphocytes are measured using specific laboratory techniques. This quantification is essential for determining the immune response.
• Step 4: Analysis and Interpretation - The results are analyzed to assess the levels of MIF. Low or absent MIF levels may indicate potential immunodeficiency, while normal levels suggest adequate immune function.

3. Post-Procedure

After the MIF test is completed, there are generally no specific post-procedure care requirements for the patient. However, it is important to monitor the patient for any immediate reactions to the blood draw, such as bruising or discomfort at the puncture site. The results of the test will be interpreted by a qualified healthcare professional, who will consider them in the context of the patient's overall clinical picture. Follow-up may be necessary to discuss the findings and any further diagnostic or therapeutic steps that may be indicated based on the results.